Trial Profile
Clinical Trials Insight: 700009615
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2005
Price :
$35
*
At a glance
- Drugs Rintatolimod (Primary) ; Antivirals
- Indications Hepatitis C; HIV-1 infections
- Focus Therapeutic Use
- 01 Dec 2005 New trial record.